Market Whales and Their Recent Bets on VKTX Options - Viking Therapeutics (NASDAQ:VKTX)

Core Insights - Investors are showing a bullish stance on Viking Therapeutics, with significant options activity indicating potential upcoming developments [1][2] - The overall sentiment among large traders is split, with 50% bullish and 25% bearish positions noted [2] - Major market movers are focusing on a price range between $25.0 and $60.0 for Viking Therapeutics over the last three months [3] Options Activity - A total of 12 options trades were detected, with 11 being calls amounting to $1,067,687 and only 1 put totaling $41,820 [2] - The mean open interest for options trades today is 1,909, with a total volume of 3,526 [4] - Significant trades include bullish call options with strike prices at $60.00 and $25.00, with total trade prices of $260.2K and $141.5K respectively [9][10] Company Overview - Viking Therapeutics specializes in biopharmaceutical development focused on metabolic and endocrine disorders, with a pipeline that includes VK2809, VK5211, and VK0214 [11] - The company is currently trading at $30.99, down by 6.03%, with a trading volume of 2,560,725 [16] - Analysts have proposed an average target price of $102.0 for Viking Therapeutics, indicating potential upside [13][14]